Autres langues Bayer AG

Actions

BAYN

DE000BAY0017

Produits pharmaceutiques

PEA

Marché Fermé - Xetra Autres places de cotation 17:35:12 05/06/2026			Varia. 5j.	Varia. 1 janv.
36,16 ^EUR	+1,69 %		-1,01 %	-2,30 %

05/06	Étude : Le finérénone de Bayer ralentit la progression de l'insuffisance rénale chronique	RE
05/06	Bayer annonce les résultats de phase III FIND-CKD pour le KERENDIA dans l'insuffisance rénale chronique non diabétique	CI

Autres langues

05/06	Studie: Bayer-Wirkstoff Finerenon verlangsamt chronische Nierenerkrankungen
05/06	Bayer Announces Phase III FIND-CKD Results For KERENDIA In Non-Diabetic Chronic Kidney Disease
05/06	UBS belässt Bayer auf 'Buy' - Ziel 52 Euro
05/06	Bayer : Finerenone significantly reduced the risk of kidney disease progression and cardiovascular outcomes in broad patient populations with CKD
05/06	Bayer : finerenone significantly reduced kidney function decline and a composite of cardiovascular-kidney outcomes versus placebo in patients with non-diabetic chronic kidney disease
05/06	Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
05/06	Morning Meeting: Bis zur Unendlichkeit und noch viel weiter
05/06	Bayer-Chef: Hormus-Blockade bedroht Ernten - Kritik an Standort Deutschland
04/06	Top cases on the US Supreme Court's docket
03/06	Afternoon Meeting: Enorme concentración de los máximos históricos en Wall Street
03/06	Wall Streets Rekordjagd der wenigen Titel
03/06	Wall Street's Record Highs Are Starting to Look a Little Narrow
03/06	Morning Meeting: Europa quiere volver a la carrera tecnológica
03/06	Morning Meeting: Europa will im Technologierennen wieder aufholen
03/06	Mwb Says Bayer Valuation Discounts US Legal Overhang; Buy Rating Kept
03/06	Bayer Rating Maintained at Buy as BofA Notes Transfer of Roundup Class Action Lawsuit
03/06	Europe wants to get back into the technology race
03/06	MORNING BRIEFING - Deutschland/Europa
03/06	Bayer Denies Restructuring Plans Despite Monsanto Lawsuits
03/06	Bayer says no plans to restructure despite litigation threat
02/06	Health Care Down as Traders Rotate to Other Defensive Sectors -- Health Care Roundup
02/06	Friedenshoffung gebremst - Technologie-Rally stützt
02/06	Germany's Blue-chip DAX Index Gains; Eurozone Inflation Accelerates
02/06	XETRA-SCHLUSS/Friedenshoffnung gebremst - Rally bei Infineon
02/06	Bayer Presents First Full FIND-CKD Results Investigating KERENDIA in Non-Diabetic Chronic Kidney Disease and Infinity Pooled Analysis At ERA 2026